Syndax Pharmaceuticals Inc (SNDX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

35 GATEHOUSE DRIVE WALTHAM, MA 02451

Syndax Pharmaceuticals is a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies. The Company's pipeline includes SNDX-5613, a highly selective inhibitor of the Menin-MLL binding interaction, axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1 (CSF-1) receptor, and entinostat, a class I HDAC inhibitor.

Data as of 2021-08-02 08:34:54 -0400
Market Cap703.464 Million Shares Outstanding48.249 Million Avg 30-day Volume399.429 Thousand
P/E Ratio-7.85546 Dividend Yield EPS-1.96
Price/Sales463.72 Debt to Equity1.23 EBITDA-83.404 Million
Price to Book Value3.08 Forward PE-0.12 Enterprise Value452.363 Million
Total Cash271.335 Million Current Debt24.568 Million Gross Profit1.517 Million
BETA1.03044 52-week High/Low27.85 / 13.02 Next Earnings Date2021-08-05 Price to Cash FLow (P/CF) -29.8803
Data provided by IEX Cloud
View SEC Filings from SNDX instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 3 5 -40.0% 3 (0.18%) 4 (0.23%) -25.0%
Funds Holding: 131 143 -8.39% 52 (3.05%) 65 (3.77%) -20.0%
13F shares: 48.474 Million 46.501 Million 4.24% 30.527 Million 31.557 Million -3.26%
% Ownership 98.5509 63.2864 66.8791 -5.37%
New Positions: 12 55 -78.18% 3 20 -85.0%
Increased Positions 55 50 10.0% 16 27 -40.74%
Closed Positions 25 10 150.0% 16 3 433.33%
Reduced Positions 44 24 83.33% 27 15 80.0%
Total Calls 243.073 Thousand 380.508 Thousand -36.12% 202.1 Thousand 283.904 Thousand -28.81%
Total Puts 170.106 Thousand 155.312 Thousand 9.53% 67.6 Thousand 62.1 Thousand 8.86%
PUT/CALL Ratio 0.7 0.41 70.73% 0.33 0.22 50.0%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding SNDX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SNDX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

EGROS FABRICE

16,000 2021-05-18 3

MEYERS MICHAEL L. SVP, CHIEF MEDICAL OFFICER

15,666 2021-04-26 2

PODLESAK DENNIS

43,300 2021-04-22 2

MORRISON BRIGGS CHIEF EXECUTIVE OFFICER

48,336 2021-02-08 3

ORDENTLICH PETER CHIEF SCIENTIFIC OFFICER

0 2021-02-03 2

METZGER MICHAEL A PRESIDENT AND COO

0 2021-02-03 4

LEGAULT PIERRE

16,000 2021-02-03 1

KATKIN KEITH

16,000 2021-02-03 1

JARRETT JENNIFER

16,000 2021-02-03 1

MEURY WILLIAM

16,000 2021-02-03 1

KARYDAS DAPHNE CHIEF FINANCIAL OFFICER

0 2021-02-03 1

SHEA RICHARD P CHIEF FINANCIAL OFFICER

7,121 2020-02-12 0

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BIOTECHNOLOGY VALUE TRADING FUND OS LP

BVF PARTNERS OS LTD.

BVF INC/IL

LAMPERT MARK N

  • 10% Owner
  • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
No longer subject to file 2018-06-18 0

EVNIN LUKE

0 2018-05-23 0

CHEN HENRY

0 2018-05-23 0

SLEDGE GEORGE W. JR.

0 2017-05-17 0

ROYSTON IVOR

625,545 2017-03-20 0

KAMDAR KIM P.

  • Director
  • 10% Owner
0 2016-10-31 0

MPM BIOVENTURES IV QP LP

SCOPA JAMES PAUL

FOLEY TODD

GADICKE ANSBERT

KAILIAN VAUGHN M

MPM ASSET MANAGEMENT INVESTORS BV4 LLC

MPM BIOVENTURES IV GMBH & CO. BETEILIGUNGS KG

MPM BIOVENTURES IV GP LLC

MPM BIOVENTURES IV LLC

MPM BIOVENTURES IV STRATEGIC FUND, L.P.

  • 10% Owner
2,168,691 2016-03-08 0

DP VIII ASSOCIATES, L.P.

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

VITULLO NICOLE

HALAK BRIAN K

  • 10% Owner
5,641 2016-03-08 0

DOMAIN PARTNERS VIII, L.P.

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

VITULLO NICOLE

HALAK BRIAN K

  • 10% Owner
761,062 2016-03-08 0

DOMAIN PARTNERS VI, L.P.

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

VITULLO NICOLE

  • 10% Owner
1,743,854 2016-03-08 0

DP VI ASSOCIATES, L.P.

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

VITULLO NICOLE

  • Director
  • 10% Owner
13,925 2016-03-08 0

SHAW ALLAN CHIEF FINANCIAL OFFICER

  • Officer
0 2016-03-02 0

DOMAIN ASSOCIATES

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

VITULLO NICOLE

HALAK BRIAN K

KAMDAR KIM P.

SHAH NIMESH

  • Director
  • 10% Owner
13,564 2016-03-02 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
SYNDAX PHARMACEUTICALS INC SNDX 2021-08-03 14:45:04 UTC -0.3048 0.3648 300000
SYNDAX PHARMACEUTICALS INC SNDX 2021-08-03 14:15:03 UTC -0.3048 0.3648 300000
SYNDAX PHARMACEUTICALS INC SNDX 2021-08-03 13:45:03 UTC -0.3048 0.3648 300000
SYNDAX PHARMACEUTICALS INC SNDX 2021-08-03 13:15:03 UTC -0.3048 0.3648 300000
SYNDAX PHARMACEUTICALS INC SNDX 2021-08-03 12:45:03 UTC -0.3048 0.3648 300000
SYNDAX PHARMACEUTICALS INC SNDX 2021-08-02 22:15:03 UTC -0.3048 0.3648 350000
SYNDAX PHARMACEUTICALS INC SNDX 2021-08-02 21:45:03 UTC -0.3048 0.3648 350000
SYNDAX PHARMACEUTICALS INC SNDX 2021-08-02 21:15:03 UTC -0.3048 0.3648 350000
SYNDAX PHARMACEUTICALS INC SNDX 2021-08-02 20:45:03 UTC -0.3048 0.3648 350000
SYNDAX PHARMACEUTICALS INC SNDX 2021-08-02 20:15:03 UTC -0.3048 0.3648 350000
SYNDAX PHARMACEUTICALS INC SNDX 2021-08-02 19:45:03 UTC -0.3048 0.3648 350000
SYNDAX PHARMACEUTICALS INC SNDX 2021-08-02 19:15:03 UTC -0.3048 0.3648 350000
SYNDAX PHARMACEUTICALS INC SNDX 2021-08-02 18:45:03 UTC -0.3048 0.3648 350000
SYNDAX PHARMACEUTICALS INC SNDX 2021-08-02 18:15:03 UTC -0.3048 0.3648 350000
SYNDAX PHARMACEUTICALS INC SNDX 2021-08-02 17:45:03 UTC -0.3048 0.3648 350000
SYNDAX PHARMACEUTICALS INC SNDX 2021-08-02 17:15:03 UTC -0.3048 0.3648 350000
SYNDAX PHARMACEUTICALS INC SNDX 2021-08-02 16:45:03 UTC -0.3065 0.3865 350000
SYNDAX PHARMACEUTICALS INC SNDX 2021-08-02 16:15:03 UTC -0.3065 0.3865 350000
SYNDAX PHARMACEUTICALS INC SNDX 2021-08-02 15:45:03 UTC -0.3065 0.3865 350000
SYNDAX PHARMACEUTICALS INC SNDX 2021-08-02 15:15:03 UTC -0.3065 0.3865 350000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Advanced Series Trust- AST Academic Strategies Asset Allocation Portfolio SNDX -4500.0 shares, $-100620.0 2021-03-31 N-PORT
First Trust Exchange-Traded Fund III- First Trust Long/Short Equity ETF SNDX -7931.0 shares, $-126420.14 2021-04-30 N-PORT

Elevate your investments